Anticoagulation Flashcards

1
Q

What does a DVT present as?

A

Usually presents as swollen, hot, red and painful leg (although can occur in other parts of the body).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do we determine the probability of a DVT?

A

Use wells DVT criteria:

Active cancer - 1
Paralysis, paresis or recent plaster - 1
Recently bedridden and/or major surgery - 1
Localised tenderness along the distribution of the deep vein system - 1
Entire leg swollen - 1
Calf swelling >3cm more than asymptomatic side - 1
Pitting oedema - 1
collateral superficial veins - 1
Alternative diagnosis - 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a D-dimer test? Is it specific?

A

A positive D-dimer indicates the presence of an abnormally high level of cross-linked fibrin degradation products in your body. It tells your doctor that there has been significant clot (thrombus) formation and breakdown in the body, but it does not identify the location or cause.

Any source of inflammation/infection can increase D-dimer not specific.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

If a patient has a low probability score, following wells criteria what do you do?

A

D-dimer test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

If a patient has a moderate or high probability score following wells criteria what do you do?

A

US - ultrasynography (color duplex scan)

D-dimer test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do we determine the probability of a PE?

A

PE wells criteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

If a patient has a moderate-high probability of PE what do we do?

A

CTPA scan (CT pulmonary angiography)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When might we use UFH?

A

In situations where it is useful to have a rapid on-off effect (as short half life, hence why given IV)

Renal impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the complications associated with UFH use?

A

under/over dosage is common
Osteoporosis risk is higher compared to LMWH
Heparin-induced thrombocytopenia (HIT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the MOA of warfarin?

A

Vitamin K antagonists.

Vitamin K epoxide reductase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the INR target with warfarin?

A

2-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What side effects are associated with warfarin?

A

bleeding, alopecia, skin rashes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Can warfarin be used in pregnancy?

A

No - teratogenic in the first semester, switch patient to LMWH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Management of warfarin overdose - in a patient with INR 6-8 with no bleeding?

A

Stop warfarin and restart when INR <5.0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Management of warfarin overdose - in a patient with INR >8 and no bleeding what do you do?

A

Stop warfarin and restart when INR <5.0

0.5-2/5mg of vit K oral or IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Management of warfarin overdose - what do you do in major bleeding?

A

Stop warfarin
Give prothrombin complex concentrate (PCC) 50U/kg
Give vit K 5mg oral or IV - give IV for higher INR values

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Why don’t we want to give too high doses of vitamin K in the management of warfarin overdose?

A

Can cause resistance to subsequent anticoagulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What anticoagulant should be used in patients if CrCl < 15?

A

Warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What anticoagulant should be used in patients if CrCl 15-30

A

Apixaban or rivaroxaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What anticoagulant should be used in children?

A

Warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What anticoagulant should be used in heart valve prosthesis?

A

Warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What anticoagulant should be used in patients with a high bleed risk?

A

Warfarin or apixaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What anticoagulant should be used in patients with CAD, previous MI or a high risk?

A

Rivaroxaban shoudl be considered - agent has a postiive effect in ACS

24
Q

What baseline monitoring is required before starting UFH?

A

INR, APTT and platelet count.

25
Q

How are LMWH doses decided?

A

Weight and renal function.

26
Q

What dose of LMWH is required for a patient weighing <50kg for VTE prophylaxis?

A

2500 U s/c OD

27
Q

What dose of LMWH is required for a patient weighing 50-100kg for VTE prophylaxis?

A

5000 U OD

28
Q

What dose of LMWH is required for a patient weighing 100-150kg for VTE prophylaxis?

A

5000U BD

29
Q

What dose of LMWH is required for a patient weighing >150kg for VTE prophylaxis?

A

7500 U BD

Might even require higher doses!

30
Q

What is the standard loading dose for warfarin? what factors might require a lower dose?

A

Loading dose is usually 10mg daily for 2 days - this is based on a 70kg patient with no co-mordities

May want to lower the dose if there is an increased risk of bleeding, elderly patients and those with impaired liver function.

31
Q

What is beriplex?

A

Pro thrombin complex concentrate, used for emergency reversal of warfarin

32
Q

What does apixaban inhibit?

A

A direct inhibitor of activator factor X (Xa)

33
Q

What does rivaroxaban inhibit?

A

A direct inhibitor of activator factor X (Xa)

34
Q

What monitoring does dabigatran require?

A

Renal function

35
Q

What does dabigatran inhibit?

A

Direct thrombin inhibitor

36
Q

What problems are associated with dabigatran?

A

Relatively large tablets
Must be stored in original packaging - should not be added to multi-compartment compliance aids.
Dexterity required to remove from packaging

37
Q

In terms of missed doses, how might the impact of this vary between NOACs and warfarin?

A

The NOACs have short half lives (less than 24 hours) compared with warfarin (about 37 hours).

38
Q

Which of the NOACS might be preferred in patients who do not want to take multiple tablets?

A

Rivaroxaban is once daily

39
Q

All patients who are started on warfarin or a NOAC should be given what?

A

All patients should be given an anticoagulant card.

40
Q

What are the differences between the arterial and venous processes involved in thrombus formation?

A

Venous thromboembolism is generally as a result of poor blood flow, which may be as a result of immobility, concurrent medication, dehydration, or vascular injury and generally results in deep vein thrombosis or pulmonary embolism.

Arterial thromboembolism, although often a result of hypercoagulability and vascular injury, results most commonly in myocardial infarction, ischaemic stroke or TIA.

41
Q

Give some examples of acquired prothrombotic risk factors

A
COC
HRT
Smoking
Long haul travel over 4 hours
Obesity - BMI over 30kg/m2
Previous history VTE
High cholesterol levels 
Co-morbidities - cancer, CVD
Pregnancy 
Surgery
42
Q

What monitoring is required with LMWH?

A

Baseline FBC, U&Es, LFTs and clotting screen.
Body weight and renal function to determine dose.
Monitor for hyperkalemia
Platelet counts after 4 days and throughout treatment

43
Q

How often is INR monitoring required with warfarin?

A

INR daily/alternate days in early treatment, then increase up to every 12 weeks.

44
Q

What is idarucizmab?

A

Dabigatran reversal agent

45
Q

How can we treat LMWH and UFH overdose?

A

Protamine sulfate is used to treat overdosage of UFH and LWMH

The long half-life of LMWH should be taken into consideration when determining the dose of protamine sulfate

46
Q

What is the normal range for the respiratory rate?

A

12-25

47
Q

What possible differential diagnoses need to be considered in a patient presenting with symptoms of a PE?

A

Chest infection, cellulitis, MI

48
Q

Why are high doses of LMWH heparin split?

A

High single doses are associated with an increased bleed risk.

49
Q

When would we consider an anti Xa test for LMWH monitoring?

A

Only in special cases - children, renal impairment, extremes of weight.

50
Q

Can LWMH be given in pregnancy?

A

Yes - does not cross the placenta.

51
Q

How do we dose LMWH in pregnancy?

A

doses are given TWICE daily (due to PK changes)

Based on pre-pregnancy or early pregnancy weight.

52
Q

How long is anticoagulation treatment continued in pregnant patients with a DVT?

A

Standard treatment is 3-6 months, must continue for 6-12 weeks post-partum.

53
Q

How should a pregnant women taking LMWH be managed when she

a) goes into labour
b) post partum

A

Treatment should be stopped at the onset of labour or if patient is having a planned casarean then it should be stopped the day before.

Post partum - depending on the circumstances and bleed risk, we normally restart in 12 hours. Go back to once daily doses!

Manage at home with either LMWH or warfarin

54
Q

What contraceptive advice would you give a women with a previous history of VTE?

A

Cannot give oestrogen containing contraceptives (COC)

Options are - POP, IUD, progesterone implant

55
Q

How do you manage VTE risk in a patient in their second pregnancy who has a VTE in their prior pregnancy?

A

Prevention LMWH should be started 4 weeks before the VTE occured in the first pregnancy.
Anti embolism stockings as soon as pregnant.

56
Q

Is LMWH safe in pregnancy?

A

Yes